| (19) |
 |
|
(11) |
EP 2 388 590 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
28.12.2011 Bulletin 2011/52 |
| (43) |
Date of publication: |
|
23.11.2011 Bulletin 2011/47 |
| (22) |
Date of filing: 02.04.2002 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
| (30) |
Priority: |
02.04.2001 US 281064 P
|
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
02757942.4 / 1383912 |
| (71) |
Applicants: |
|
- Dana-Farber Cancer Institute, Inc.
Boston, MA 02115 (US)
- Wyeth LLC
Madison, NJ 07940 (US)
|
|
| (72) |
Inventors: |
|
- Freeman, Gordon J.
Brookline, MA 02146 (US)
- Wood, Clive
Boston, MA 02114 (US)
- Chaudhary, Divya
Andover, MA 01810 (US)
|
| (74) |
Representative: Raggers, René John |
|
Exter Polak & Charlouis B.V.
P.O. Box 3241
2280 GE Rijswijk
2280 GE Rijswijk (NL) |
|
| |
|
|
|
Remarks: |
|
This application was filed on 15-11-2010 as a divisional application to the application
mentioned under INID code 62. |
|
|
|
Remarks: |
|
Claims filed after the date of filing of the application / after the date of receipt
of the divisional application (Rule 68(4) EPC). |
|
| (54) |
PD-1, a receptor for B7-4, and uses thereof |
(57) Assays for identifying compounds which modulate signaling via PD-1 are disclosed.